Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study

2009 ◽  
Vol 28 (3) ◽  
pp. 299-305 ◽  
Author(s):  
Mei Li ◽  
Xiao-ping Xing ◽  
Zhen-lin Zhang ◽  
Jian-li Liu ◽  
Zhong-lan Zhang ◽  
...  
Nutrients ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 2090
Author(s):  
Christa Ellis ◽  
Herculina S Kruger ◽  
Michelle Viljoen ◽  
Joel A Dave ◽  
Marlena C Kruger

The study aimed to determine factors associated with changes in bone mineral density (BMD) and bone resorption markers over two years in black postmenopausal women living with human immunodeficiency virus (HIV) on antiretroviral therapy (ART). Women (n = 120) aged > 45 years were recruited from Potchefstroom, South Africa. Total lumbar spine and left femoral neck (LFN) BMD were measured with dual energy X-ray absorptiometry. Fasting serum C-Telopeptide of Type I collagen (CTx), vitamin D and parathyroid hormone were measured. Vitamin D insufficiency levels increased from 23% at baseline to 39% at follow up. In mixed linear models serum CTx showed no change from baseline to end (p = 0.363, effect size = 0.09). Total and LFN BMD increased significantly over two years, but effect sizes were small. No significant change in spine BMD over time was detected (p = 0.19, effect size = 0.02). Age was significantly positively associated with CTx over time, and negatively with total and LFN BMD. Physical activity (PA) was positively associated with LFN BMD (p = 0.008). Despite a decrease in serum vitamin D, BMD and CTx showed small or no changes over 2 years. Future studies should investigate PA interventions to maintain BMD in women living with HIV.


Sign in / Sign up

Export Citation Format

Share Document